KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
2.520
-0.030 (-1.18%)
Jun 26, 2026, 4:00 PM EDT - Market closed
KALA BIO Employees
KALA BIO had 6 employees as of December 31, 2025. The number of employees decreased by 32 or -84.21% compared to the previous year.
Employees
6
Change (1Y)
-32
Growth (1Y)
-84.21%
Revenue / Employee
n/a
Profits / Employee
-$3,275,667
Market Cap
46.85M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Mereo BioPharma Group | 39 |
| PDS Biotechnology | 21 |
| Veru Inc. | 20 |
| Lantern Pharma | 16 |
| CervoMed | 15 |
| Apollomics | 14 |
| Actuate Therapeutics | 12 |
| Eloxx Pharmaceuticals | 10 |
KALA News
- 16 days ago - KALA BIO Registration statement: Registration filing - Filings
- 6 weeks ago - KALA BIO Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Kala Bio falls -21.7% - TheFly
- 7 weeks ago - KALA BIO Announces Reverse Stock Split - GlobeNewsWire
- 7 weeks ago - KALA BIO Registration statement: Registration filing - Filings
- 2 months ago - Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine - GlobeNewsWire
- 2 months ago - KALA BIO Annual report: Q4 2025 - Filings
- 3 months ago - Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities - GlobeNewsWire